ASHLEY MCBRIDE: Open Payments
NPI 1427797851 · IRVINGTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 56 payments from 17 companies in 2025. Trend: 2023 $252 · 2024 $350 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $233 |
| Novo Nordisk Inc | 13 | $206 |
| SANOFI-AVENTIS U.S. LLC | 5 | $116 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
Products named: Wegovy, TZIELD, QULIPTA, VRAYLAR, Enhertu, Auvelity, Rybelsus, MAVYRET.
Industry payments across AL — which companies pay providers there.
